Ginsenoside Rb1, a principal effective ingredient of Panax notoginseng, produces pain antihypersensitivity by spinal microglial dynorphin A expression.

MLA

Shoaib, Rana Muhammad, et al. “Ginsenoside Rb1, a Principal Effective Ingredient of Panax Notoginseng, Produces Pain Antihypersensitivity by Spinal Microglial Dynorphin A Expression.” Neuroscience Research, vol. 188, Mar. 2023, pp. 75–87. EBSCOhost, https://doi.org/10.1016/j.neures.2022.11.003.

APA

Shoaib, R. M., Ahsan, M. Z., Akhtar, U., Ahmad, K. A., Ali, U., Deng, M.-Y., Li, X.-Y., & Wang, Y.-X. (2023). Ginsenoside Rb1, a principal effective ingredient of Panax notoginseng, produces pain antihypersensitivity by spinal microglial dynorphin A expression. Neuroscience Research, 188, 75–87. https://doi.org/10.1016/j.neures.2022.11.003

Chicago

Shoaib, Rana Muhammad, Muhammad Zaeem Ahsan, Usman Akhtar, Khalil Ali Ahmad, Usman Ali, Men-Yan Deng, Xin-Yan Li, and Yong-Xiang Wang. 2023. “Ginsenoside Rb1, a Principal Effective Ingredient of Panax Notoginseng, Produces Pain Antihypersensitivity by Spinal Microglial Dynorphin A Expression.” Neuroscience Research 188 (March): 75–87. doi:10.1016/j.neures.2022.11.003.